GUIDE
to
xyntha
CLOSE

GUIDE TO
XYNTHA

Guide

Download Arrow

Download
GUIDE TO XYNTHA
as PDF

guide
to
xyntha

the xyntha dual
chamber device

XYNTHA dual chamber is the latest innovation from Pfizer.

It’s the only haemophilia device available in New Zealand that’s preloaded with both factor VIII and diluent for quick and convenient treatment.

No need for transfer, it’s already done.

Available in an all-inclusive kit, the XYNTHA dual chamber syringe features an innovative all-in-one convenient design that eliminates the transfer step for ease of reconstitution.

XYNTHA, it’s ready to go when you are.

Diluent

Before using Xyntha

Do not begin treatment if:
  • You are allergic to hamster proteins or any other component of XYNTHA.
  • You have von Willebrand’s disease. XYNTHA does not contain von Willebrand factor.
  • Your XYNTHA kit is past the expiry date printed on the pack.
  • Your XYNTHA packaging is torn or shows signs of tampering.

Please click here for further information on Xyntha

Infusion Set

How to use Xyntha?

Green Arrow Up
Download PDF Button

Download
Guide to Xyntha
as PDF

XYNTHA (moroctocog alfa (rch) (recombinant coagulation factor VIII))
250 IU, 500 IU, 1000 IU, 2000 IU, 3000 IU

XYNTHA (moroctocog alfa (rch)) is a funded medicine that is prescribed by a doctor for the control and treatment of bleeding and the routine and surgical prevention of bleeding in patients with haemophilia A. A pharmacy charge and normal doctor’s fees apply. Xyntha has risks and benefits. XYNTHA contains trace amounts of hamster protein. You may develop an allergic reaction to these proteins. Tell your doctor if you have had an allergic reaction to hamster protein or any of the other ingredients of XYNTHA. XYNTHA must be used with caution in certain people, including: people with factor VIII inhibitors, people with allergies, people changing from other factor VIII medicines to XYNTHA, and pregnant or breastfeeding women. Ask your doctor for advice. Uncommon to very rare serious side effects include numbness, chest pain, rapid or irregular heartbeat, shortness of breath, bleeding and low blood pressure. If you have side effects see your doctor. If you suddenly experience a swollen face, lips, tongue or throat, shortness of breath, chest tightness, wheezing, dizziness, faintness, chills, flushing, tiredness, restlessness, nausea, vomiting, rapid heartbeat, headache, tingling, burning and stinging at the injection site, hives or skin rash, STOP taking XYNTHA and seek urgent medical attention. These may be signs of a serious allergic reaction. Tell your doctor immediately if you are using increasing amounts of XYNTHA in order to control a bleeding episode. Use strictly as directed. Consult your doctor to see if XYNTHA is right for you. Contains moroctocog alfa (rch) 250, 500, 1000, 2000, 3000 IU/vial or syringe.

Further information on XYNTHA is available from www.medsafe.govt.nz or Pfizer New Zealand Limited, Auckland, www.pfizer.co.nz. Ph. 0800 736 363. V11216 Pfizer New Zealand, Level 1, Suite 1.4, Building B, 8 Nugent Street, Grafton, Auckland 1023. PPZR0332 PP-XYN-NZL-0063, NA 9403 09/17.

XYNTHA® is a registered trademark.
© Pfizer 2017

www.medsafe.govt.nz

www.haemophilia.org.nz

© 2017 Pfizer New Zealand Limited, Auckland. All rights reserved.

Privacy Policy  |  Legal Policy